Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis

Endocrinology

Volumn 138, Issue 6, 1997, Pages 2552-2558

  Scrimgeour, Angus G ^a   Blakesley, Vicky A ^a   Stannard, Bethel S ^a   Leroith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C;

ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; LIPOGENESIS; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

EID: 0030996380     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.6.5215     Document Type: Article

References (45)

1. Kadowaki T, Koyasu S, Nishida E, Tobe K, Izumi T, Takaku F, Sakai H, Yahara I, Kasuga M 1987 Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor 1, and epidermal growth factor in an intact cell. J Biol Chem 262:7342-7350
2. Rosenzweig SA, Oemar BS, Law NM, Shankavaram UT, Miller BS 1994 Insulin like growth factor 1 receptor signal transduction to the nucleus. In: LeRoith D, Raizada MK (eds) Current Directions in Insulin-like Growth Factor Research. Plenum Press, New York, pp 159-168
3. Roth RA, Zhang B, Chin JE, Kovacina K 1992 Substrates and signaling complexes: the tortured path to insulin action. J Biol Chem 48:12-18
4. Cobb MH, Hepler JE, Cheng M, Robbins D 1994 The mitogen-activated protein kinases, ERK1 and ERK2. Semin Cancer Biol 5:261-268
5. Williams NG, Paradis H, Agarwal S, Charest DL, Pelech SL, Roberts TM 1993 Raf-1 and p21v-ras cooperate in the activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 90:5772-5776
6. Sontag E, Fedorov S, Kamibayashi C, Robbins D, Cobb M, Mumby M 1993 The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the MAP kinase pathway and induces cell proliferation. Cell 75:887-897
7. Chung J, Chen RH, Blenis J 1991 Coordinate regulation of pp90rsk and a distinct-protein serine/threonine kinase activity that phosphorylates recombinant pp90rsk in vitro. Mol Cell Biol 11:1868-1874
8. 2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts. J Biol Chem 263:5396-5401
9. Mastick DD, Kato H, Roberts Jr CT, LeRoith D, Saltiel AR 1994 Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation. Endocrinology 135:214-222
10. Dent P, Haser W, Haystead TA, Vincent LA, Roberts Sturgill TW 1992 Activation of mitogen-activated protein kinase kinase by v-Raf in NIH-3T3 cells and in vitro. Science 257:1404-1407
11. Gallego C, Gupta SK, Heasley L, Qian NX, Johnson GL 1992 Mitogen-activated protein kinase activation resulting from selective oncogene expresssion in NIH-3T3 cells and Rat 1a cells. Proc Natl Acad Sci USA 89:7355-7359
12. Kyriakis JM, App H, Zhang X-F, Banerjee P, Brautigan DL, Rapp UR, Avruch J 1992 Raf-1 activates MAP kinase kinase. Nature 358:417-421
13. Ruderman JV 1993 MAP kinase and the activation of quiescent cells. Curr Opin Cell Biol 5:207-213
14. Cowley S, Paterson H, Kemp P, Marshall CJ 1994 Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852
15. Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyriakis J, Banerjee P, Avruch J, Rapp UR 1994 Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphobol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 269:7030-7035
16. Ruderman NB, Kapeller R, White MF, Cantley LC 1990 Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci USA 87:1411-1415
17. Endemann G, Yonezawa K, Roth RA 1990 Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J Biol Chem 265:396-400
18. Backer JM, Myers Jr MG, Shoelson SE, Chin DJ, Sun X-J, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF 1992 Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479
19. Yamamoto K, Palpetina EG, Mowham CP 1992 Insulin-like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor. Endocrinology 130:1490-1498
20. Giorgetti S, Ballotti R, Kowalski-Chaubel A, Tartare S, Van Obberghen E 1993 The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J Biol Chem 268:7358-7364
21. Kooijman R, Lauf JJ, Kappers AC, Rijkers GT 1995 Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol 3-kinase in human thymocytes. J Exp Med 182:593-597
22. Ui M, Okada T, Hazeki K, Hazeki O 1995 Wortmannin as an unique probe for an intracellular signaling protein, phosphatidylinositide 3-kinase. Trends Biochem Sci 20:303-307
23. Kapeller R, Cantley LC 1994 Phosphatidylinositol 3-kinase. Bioessays 16:565-576
24. Li S, Resnicoff M, Baserga R 1996 Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor-I receptor. J Biol Chem 271:12254-12260
25. Blakesley VA, Kalebic T, Helman LJ, Stannard B, Faria TN, Roberts Jr CT, LeRoith D 1996 Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor. Endocrinology 137:410-417
26. Hernández-Sánchez C, Blakesley VA, Kalebic T, Helman L, LeRoith D 1995 The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis. J Biol Chem 270:29176-29181
27. Hongo A, D'Ambrosio C, Miura M, Morrione A, Baserga R 1996 Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12:1231-1238
28. Miura M, Li S, Baserga R 1995 Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res 55:663-667
29. Blakesley VA, Stannard B, Kalebic T, Helman LJ, LeRoith D 1997 The role of the IGF-I receptor in mutagenesis and tumor promotion. J Endocrinol 152:339-344
30. Miura M, Surmacz E, Burgaud J-L, Baserga R 1995 Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem 270:22639-22644
31. Kato H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor: characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (aIR-3). J Biol Chem 268:2655-2661
32. Kato H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D 1994 Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol 8:40-50
33. Bradford M 1976 A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
34. Seger R, Ahn NG, Posada J, Munar ES, Jensen AM, Cooper JA, Cobb MH, Krebs EG 1992 Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J Biol Chem 267:14373-14381
35. Webster J, Prager D, Melmed S 1994 Insulin-like growth factor-I activation of extracellular signal-related kinase-1 and -2 in growth hormone-secreting cells. Mol Endocrinol 8:539-544
36. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R 1994 Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612
37. Fantl WJ, Johnson DE, Williams LT 1993 Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453-481
38. Macara IG, Marinetti GV, Balduzzi PC 1984 Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis. Proc Natl Acad Sci USA 81:2728-2732
39. Sugimoto Y, Erickson RL 1985 Phosphatidylinositol kinase activities in normal and Rous sarcoma virus-transformed cells. Mol Cell Biol 5:3194-3198
40. Párrizas M, Saltiel AR, LeRoith D 1997 Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272:154-161
41. Koval AP, Blakesley VA, Zick Y, LeRoith D 1996 In vitro interaction of CRK with the insulin-like growth factor-I receptor. Tenth International Congress of Endocrinology, San Francisco CA, OR 34-3
42. Furlanetto RW, Lopacznyski W, Day B, Nissley SP 1996 14-3-3 proteins interact with the IGF-I receptor. Tenth International Congress of Endocrinology, San Francisco CA, OR 31-6
43. Beitner-Johnson D, LeRoith D 1995 Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J Biol Chem 270:5187-5190
44. Matsuda M, Hashimoto Y, Moroya K, Hasegawa H, Kurata T, Tanaka S, Nakamura S, Hattori S 1994 CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol 14:5495-5500
45. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, T WL 1994 Activation of Rat-1 by 14-3-3 proteins. Nature 371:612-614